-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $10

Benzinga·01/15/2026 15:11:41
Listen to the news
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $9.5 to $10.